leukoreduced blood components
Biologicalexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jul 1, 2006 (NCT00810810)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- BloodSupplementation
Blood supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- leukoreduced blood components
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00810810 | Phase 4 | Jul 1, 2006 | National Heart, Lung, and Blood Institute (NHLBI), Puget Sound Blood Center, University of Washington |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2006 |
| Puget Sound Blood Center | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2006 |
3 organizations
Page 1 / 1